GSK CEO Reiterates China Commitment Despite Past Year's Double Hit
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline's latest financial report showing still-dropping sales has not deterred the company from its commitment to remain on the China market at the center of its revenue decline, its CEO said.